Pharmaceutical services in pediatric oncology: A scoping review
- 28 May 2026
- journal article
- review article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
Abstract
Background: Although the role of pharmacists in pediatric oncology is well established, scientific production explicitly characterizing the services provided in this field remains limited. Objective: To map studies on pharmaceutical services in pediatric oncology. Methods: A scoping review was conducted in accordance with the JBI Manual for Evidence Synthesis and reported following the PRISMA-ScR Checklist. A systematic search was performed in September 2024 across six electronic databases, gray literature, and reference lists of selected studies. Eligible studies included original research and systematic reviews addressing pharmaceutical services in pediatric oncology. Two researchers independently assessed eligibility and extracted data, which were presented descriptively. Results: Twenty-two articles were included, of which 86.4% (n = 19) were conducted in countries with a very high or high Human Development Index (HDI). Most studies were carried out in hospitals (86.4%; n = 19), with inpatient care being the most frequently addressed setting (54.6%; n = 12). The pharmaceutical services described mainly focused on pharmacotherapy follow-up (46.4%), followed by prescription analysis (18.2%) and compounding of antineoplastic agents (18.2%). In 72.7% (n = 16) of the studies, services were offered in autonomy. Regarding outcomes, 68.2% (n = 15) focused on clinical endpoints. Observational studies predominated (91%; n = 20). Conclusion: The most frequently identified pharmaceutical services in pediatric oncology were pharmacotherapy follow-up, prescription analysis, and compounding of antineoplastic agents, generally provided autonomously within hospital and outpatient settings. These findings highlight the relevance of pharmacists’ role in this field while underscoring the need for more interventional studies evaluating clinical and economic outcomes.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
This publication has 18 references indexed in Scilit:
- Implementation of Clinical Pharmacy Services in Primary Health Care: A Scoping ReviewJournal of Evaluation in Clinical Practice, 2025
- Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: A systematic reviewJournal of Geriatric Oncology, 2023
- Practicing and evaluating clinical pharmacy in oncology: Where are we now? A scoping reviewResearch in Social and Administrative Pharmacy, 2023
- Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysisEuropean Journal of Cancer Care, 2022
- Best practice guidance and reporting items for the development of scoping review protocolsJBI Evidence Synthesis, 2022
- Ethical Challenges in Pediatric Oncology Care and Clinical Trials2021
- Updated methodological guidance for the conduct of scoping reviewsJBI Evidence Implementation, 2021
- The impact of pharmacist‐led strategies implemented to reduce errors related to cancer therapies: a systematic reviewJournal of Pharmacy Practice and Research, 2020
- Multidisciplinary practice advancement: Role of a clinical pharmacy specialist in a pediatric specialty clinicAmerican Journal of Health-System Pharmacy, 2020
- International incidence of childhood cancer, 2001–10: a population-based registry studyThe Lancet Oncology, 2017